Chemours (CC) Tops Q3 EPS by 14c

Chemours (NYSE: CC) reported Q3 EPS of $0.40, $0.14 better than the analyst estimate of $0.26. Revenue for the quarter came in at $1.49 billion versus the consensus estimate of $1.52 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• KULR Technology Group (KULR) Misses Q2 EPS by 39c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c